A novel once weekly insulin, insulin icodec, (an experimental basal insulin analogue) was found to be as safe and effective as once daily insulin glargine in a Phase 2 trial. No study participants had previously received long term insulin treatment. The 250 study participants were on metformin with or without a DPP-IV inhibitor, and with hemoglobin A1c (A1c) above 7%. A similar drop in A1c was seen in both groups as well as both groups had low incidence of clinically significant or severe hypoglycemia. To learn more, please click below.
Please share your thoughts and subscribe to receive my blogs.
#novel #diabetes #weekly #insulin
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.